COX2 inhibitors for acquired brain injuries: is the time ripe?
- PMID: 20083946
- PMCID: PMC3313841
- DOI: 10.1097/CCM.0b013e3181bc80b9
COX2 inhibitors for acquired brain injuries: is the time ripe?
Conflict of interest statement
The author has not disclosed any potential conflicts of interest.
Comment on
-
Cyclooxygenase-2 inhibition provides lasting protection against neonatal hypoxic-ischemic brain injury.Crit Care Med. 2010 Feb;38(2):572-8. doi: 10.1097/CCM.0b013e3181cb1158. Crit Care Med. 2010. PMID: 20029340 Free PMC article.
References
-
- Bell MJ, Kochanek PM, Doughty LA, et al. Interleukin-6 and interleukin-10 in cerebro-spinal fluid after severe traumatic brain injury in children. J Neurotrauma. 1997;14:451–457. - PubMed
-
- Blom MA, van Twillert MG, de Vries SC, et al. NSAIDS inhibit the IL-1 beta-induced IL-6 release from human post-mortem astrocytes: The involvement of prostaglandin E2. Brain Research. 1997;777:210–218. - PubMed
-
- Minghetti L. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol. 2004;63:901–910. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials